Safety and Efficacy of the Multitargeted Receptor Kinase Inhibitor Pazopanib in the Treatment of Corneal Neovascularization

PURPOSE. To evaluate the safety and efficacy of topical pazopanib in the treatment of corneal neovascularization (CNV). METHODS. Twenty eyes of 20 patients with stable CNV were enrolled in a prospective, open label, noncomparative study and treated with topical pazopanib 0.5% for 3 weeks, and follow...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Amparo, Francisco, Sadrai, Zahra, Jin, Yiping, Alfonso-Bartolozzi, Belen, Wang, Haobing, Shikari, Hasanain, Ciolino, Joseph B., Chodosh, James, Jurkunas, Ula, Schaumberg, Debra A., Dana, Reza
Format: Artigo
Jezik:Inglês
Izdano: The Association for Research in Vision and Ophthalmology 2013
Teme:
Clinical Trials
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3558296/
https://ncbi.nlm.nih.gov/pubmed/23233252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.12-11032
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items